Upregulation of Jagged1 in tumor ECs leads to increased activation of Notch2 in lymphoma cells, which take on a more aggressive phenotype, that is more stem-like, invasive and displays increased chemoresistance [131]. The gene discussed is JAG1; the disease is neoplasm.